CollPlant Biotechnologies (CLGN) Return on Capital Employed (QoQ) (2020 - 2025)

CollPlant Biotechnologies (CLGN) Return on Capital Employed (QoQ) (2020 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 CollPlant Biotechnologies 4.63 Mn 4.63 Mn -243,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -718.00
Dec 31, 2024 1,198.00
Sep 30, 2024 74.00
Jun 30, 2024 -1,176.00
Mar 31, 2024 589.00
Dec 31, 2023 -298.00
Sep 30, 2023 -60.00
Jun 30, 2023 2,913.00
Mar 31, 2023 -247.00
Dec 31, 2022 -488.00
Sep 30, 2022 -509.00
Jun 30, 2022 -347.00
Mar 31, 2022 -1,321.00
Dec 31, 2021 347.00
Sep 30, 2021 -889.00
Jun 30, 2021 -11,596.00
Mar 31, 2021 23,096.00
Dec 31, 2020 -3,954.00
Sep 30, 2020 1,188.00
Jun 30, 2020 -3,518.00